pt en


GenoMed is a spin-off company of iMM Lisboa created in 2004. The mission of GenoMed is to provide cutting-edge technology transfer services relevant for medical applications. Currently, GenoMed offers over 100 different tests that are used in diagnosis, prognosis and therapeutic follow up. GenoMed acts in 3 main medical areas:

Oncology: Molecular and Cytogenetics tests for Hemato-Oncology, including follow up of bone marrow transplantation. Molecular diagnosis (FISH) for Oligodendrogliomas and urinary tract cancer. Hereditary breast cancer.

Infectious Diseases: Sequencing the HIV genome to detect resistance to anti-viral therapy. Genotyping Hepatitis B and C genomes and detecting resistance to anti-viral therapy.
Genotyping Human Papillomavirus. Infection by Aspergillus in immuno suppressed patients: detection of Galactomannan Antigen.

Genetic Diseases: Alzheimer and Parkinson diseases; Fronto-Temporal Dementia. Wilson Disease, Hemochromatosis, Porphyria. Hyperthropic cardiomyopathy; Familiar Hypercholesterolemia; Brugada and Long QT Syndromes. Bone Dysplasias.

Pharmacogenetics: Genetic testing to reduce bleeding associated with Warfarin intake. Genetic testing for management of antidepressive drug therapy. Additionally, GenoMed provides parental and ancestry DNA testing.

Chief Executive Officer
Maria Carmo-Fonseca

This site uses cookies. Some of the cookies we use are essential for parts of the site to operate and have already been set.
You may delete and block all cookies from this site, but parts of the site will not work.